Disclosures for "Highly Purified Cannabidiol (CBD) Use and Therapeutic Drug Monitoring in Pregnancy: A Case Report"
-
Dr. Dadhich has nothing to disclose.
-
Dr. Gaston has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. The institution of Dr. Gaston has received research support from NINDS.